Jennifer Doudna and David Liu talk with Senior Editor Markus Elsner about the state of the genome-editing field and what challenges remain, especially as various therapies are now entering the clinic.
About this article
Cite this article
Forum: CRISPR roundtable with Doudna and Liu. Nat Biotechnol 38, 943 (2020). https://doi.org/10.1038/s41587-020-0619-8